-
Alexion’s Koselugo approved in US for adults with neurofibromatosis type 1
21 Nov 2025 05:52 GMT
… treatment of adult patients with neurofibromatosis type 1 (NF1) who have …
-
<![CDATA[FDA Approves Selumetinib for Adults With Neurofibromatosis Type 1]]>
21 Nov 2025 03:59 GMT
… the treatment of adults with neurofibromatosis type 1 (NF1) who have … the US for adults with neurofibromatosis type 1. News release. AstraZeneca … of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable …
-
Alexion, AstraZeneca Rare Disease Koselugo gets USFDA nod for neurofibromatosis type 1
21 Nov 2025 01:35 GMT
… treatment of adult patients with neurofibromatosis type 1 (NF1) who have …
-
<![CDATA[Selumetinib Is Approved for Adults With Neurofibromatosis Type 1 With Plexiform Neurofibromas]]>
20 Nov 2025 05:21 GMT
… FDA approval for adults with neurofibromatosis type 1 (NF1) who have … New FDA-Approved Drug for Neurofibromatosis. Indian Dermatol Online J. 2024 …
-
FDA approves selumetinib for adults with neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas
19 Nov 2025 16:19 GMT
… Pharmaceuticals LP) for adults with neurofibromatosis type 1 (NF1) who have … central review (Response Evaluation in Neurofibromatosis and Schwannomatosis criteria). Duration of …
-
Patient-led group provides social, community support for neurofibromatosis sufferers
15 Nov 2025 10:09 GMT
… a rare genetic condition called neurofibromatosis have come together to provide … formed a group, called the Neurofibromatosis Society (NFS) Singapore, which was … Registry of Societies in August.
Neurofibromatosis, or NF, is a rare …
-
EU Approves Alexion’s Koselugo for Adults with Neurofibromatosis Type 1
29 Oct 2025 13:26 GMT
… (PN) in adult patients with neurofibromatosis type 1 (NF1). This marks …
-
Koselugo approved in EU for plexiform neurofibromas in adults with neurofibromatosis type 1: AstraZeneca
29 Oct 2025 08:25 GMT
… (PN) in adult patients with neurofibromatosis type 1 (NF1).
The approval …
-
EU approves Alexion's Koselugo for plexiform neurofibromas in adults with neurofibromatosis type 1
29 Oct 2025 05:46 GMT
… (PN) in adult patients with neurofibromatosis type 1 (NF1).
The approval …
-
AstraZeneca's Koselugo approved in EU for neurofibromatosis
28 Oct 2025 10:41 GMT
… Alexion, for the treatment of neurofibromatosis type 1, a skin condition … a Phase III clinical trial.
Neurofibromatosis type 1, which manifests itself …